Home » Stocks » NSTG

NanoString Technologies, Inc. (NSTG)

Stock Price: $57.65 USD -1.47 (-2.49%)
Updated Jun 16, 2021 9:37 AM EDT - Market open
Market Cap 2.76B
Revenue (ttm) 122.33M
Net Income (ttm) -99.17M
Shares Out 44.67M
EPS (ttm) -2.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 16
Last Price $57.65
Previous Close $59.12
Change ($) -1.47
Change (%) -2.49%
Day's Open -
Day's Range 57.65 - 59.12
Day's Volume 13,790
52-Week Range 28.50 - 86.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SEATTLE & SAN FRANCISCO--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and the Parker Institute for Ca...

1 day ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the Jefferies Virtual Healthcare conference.

2 weeks ago - Business Wire

10x Genomics stock has fallen, despite announcing strong first-quarter numbers.

Other stocks mentioned: ILMN, TXG
3 weeks ago - The Motley Fool

SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the UBS Global Healthcare Conference.

3 weeks ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of ...

4 weeks ago - Business Wire

NanoString (NSTG) delivered earnings and revenue surprises of -6.90% and 5.19%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

SEATTLE--(BUSINESS WIRE)--NanoString Reports First Quarter 2021 Operating Results.

1 month ago - Business Wire

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

Other stocks mentioned: MRVI, SDC, SWAV, TGTX
1 month ago - Zacks Investment Research

SEATTLE--(BUSINESS WIRE)--NanoString announced today that a peer-reviewed publication using the GeoMx® Digital Spatial Profiler is to be published in the journal Nature.

1 month ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString announces spatial biology highlights from the 2021 American Association of Cancer Research Conference.

2 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString announces date of First Quarter 2021 Operating Results and Conference Call on Monday, May 10, 2021

2 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString's GeoMx DSP reveals insights into COVID-19 in two new publications in Nature.

2 months ago - Business Wire

Investors saw some downwards pressure on the indices to kick off Monday. But Q.ai's deep learning algorithms have crunched the numbers to bring you today's top short plays.

Other stocks mentioned: ARVN, CVNA, PLUG, RDFN
2 months ago - Forbes

After the market sold off on the first anniversary of the bull market yesterday, investors saw renewed signs of recovery. Meanwhile, the deep learning algorithms at Q.ai have crunched the data to give y...

Other stocks mentioned: CVNA, MUR, PLUG
2 months ago - Forbes

SEATTLE--(BUSINESS WIRE)-- #spatialbiology--NanoString enters spatial biology collaboration with Illumina Accelerator and Doloromics.

2 months ago - Business Wire

Just as quickly as Nasdaq NDAQ hit correction territory twice in the last week, it saw sharp gains. Meanwhile, Q.ai's deep learning algorithms have brought you today's top shorts.

Other stocks mentioned: CDLX, LAUR, TRIP, X
3 months ago - Forbes

SEATTLE--(BUSINESS WIRE)--NanoString Technologies announced the appointment of two new board members, Dr. Dana Rollison and Janet George, effective March 8, 2021.

3 months ago - Business Wire

The rotation into recovery continues as President Biden's stimulus proposal passed through the Senate. To make the most of this market, Q.ai's Artificial Intelligence has assessed each firm to find toda...

Other stocks mentioned: CALM, RDFN, SFIX, X
3 months ago - Forbes

NanoString (NSTG) delivered earnings and revenue surprises of -12.77% and 1.72%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of NanoString Technologies (NASDAQ:NSTG) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 15.87% year over year to ($0.53), ...

3 months ago - Benzinga

SEATTLE--(BUSINESS WIRE)--NanoString releases Q4 and FY20 operating results.

3 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString announces highlights of 2021 Advances in Genome Biology and Technology conference.

3 months ago - Business Wire

NanoString Technologies (NASDAQ:NSTG) unveils its next round of earnings this Monday, March 01. Get prepared with Benzinga's ultimate preview for NanoString Technologies's Q4 earnings.

3 months ago - Benzinga

SEATTLE--(BUSINESS WIRE)--NanoString to present at the 41st annual Cowen healthcare conference.

3 months ago - Business Wire

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

SEATTLE--(BUSINESS WIRE)--NanoString announces launch of GeoMx DSP Whole Transcriptome Atlas.

3 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString to present at 10th Annual SVB Leerink conference.

3 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString to release Q4 and FY20 operating results on March 1st, 2021.

4 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in th...

4 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString provides preliminary financial and operational highlights for Q4'20.

5 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString to webcast presentation from the JP Morgan Healthcare conference.

5 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString's GeoMx DSP Identifies Diverse Immune Responses in COVID-19 Patients.

6 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString announces development of spatial molecular imaging platform.

6 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString announces virtual Investor and Analyst Day.

6 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString and OHSU Announce Collaboration to Develop GeoMx Assays for Breast Cancer

6 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString to present at the 2020 Stifel Healthcare Conference.

7 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString announces research highlights from SITC 2020.

7 months ago - Business Wire

NanoString Technologies, Inc. (NSTG) CEO Bradley Gray on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

NanoString (NSTG) delivered earnings and revenue surprises of 8.20% and 5.68%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

Shares of NanoString Technologies (NASDAQ:NSTG) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 1.56% over the past year to ($0.65), wh...

7 months ago - Benzinga

SEATTLE--(BUSINESS WIRE)--NanoString reports Q3 operating results.

7 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString announces commercial launch of spatially resolved protein analysis using next generation sequencing.

7 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString to present at virtual Credit Suisse Healthcare conference.

7 months ago - Business Wire

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the closing of its previously an...

8 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-b...

8 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString announces pricing of upsized public stock offering.

8 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString Announces Commencement of Public Offering of Common Stock

8 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString announces preliminary operating results for third quarter of FY20.

8 months ago - Business Wire

SEATTLE--(BUSINESS WIRE)--NanoString announces date of third quarter earnings call.

8 months ago - Business Wire

About NSTG

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from... [Read more...]

Industry
Biotechnology
IPO Date
Jun 26, 2013
CEO
R. Bradley Gray
Employees
579
Stock Exchange
NASDAQ
Ticker Symbol
NSTG
Full Company Profile

Financial Performance

In 2020, NSTG's revenue was $117.32 million, a decrease of -6.57% compared to the previous year's $125.57 million. Losses were -$110.08 million, 170.5% more than in 2019.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for NSTG stock is "Buy." The 12-month stock price forecast is 75.40, which is an increase of 30.79% from the latest price.

Price Target
$75.40
(30.79% upside)
Analyst Consensus: Buy